| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |